CEO & President
JC Medical and Genesis MedTech
Providence, Rhode Island, United States
Dr. Mark Turco is an experienced clincal, scientific and business executive.
Dr. Turco spent over 7 years working for large cap medical device companies, serving as Vice President and Chief Medical Officer of the vascular and neuro franchises for Medtronic, Inc. and Covidien, plc and then as the Chief Innovation Officer at the University of Pennsylvania.
Dr. Turco is currently the CEO of JC Medical and President, North American Vascular Intervention for Genesis Medtech. JC Medical is a fully owned subsidiary of Genesis MedTech and a clinincal stage company with its initial offering a TAVR valve for the treatment of paitnets with Aortic Regurgitation.
He practiced as an interventional cardiologist in the Washington, D.C. area for 16 years, serving as Director of the Cardiovascular Research Center at Washington Adventist Hospital, Takoma Park, MD. Dr. Turco has numerous publication to his credit.
Disclosure information not submitted.
CAREER OPPORTUNITIES AFTER THE CATH LAB
Sunday, March 9, 2025
2:00 PM – 3:05 PM ET
Sunday, March 9, 2025
2:55 PM – 3:05 PM ET
CRT 2025 BEST INNOVATIONS COMPETITION
Monday, March 10, 2025
2:40 PM – 5:30 PM ET
FINAL REFERRAL and PANEL DISCUSSION
Monday, March 10, 2025
4:50 PM – 5:20 PM ET
Panel Discussion | Second- and Third-Generation Aortic Valve Systems Not Yet Approved in the US
Tuesday, March 11, 2025
9:44 AM – 10:00 AM ET
Panel Discussion: Innovative Technology Headwinds and Tailwinds
Tuesday, March 11, 2025
8:32 AM – 8:50 AM ET
Tuesday, March 11, 2025
9:00 AM – 9:20 AM ET